Analyst Upgrades

• Deere (DE) to outperform from market perform at Wells Fargo.
• American Eagle (AEO) to buy from neutral at Janney Capital.
• FedEx (FDX) and Shaw (SJR) to outperform from neutral at Credit Suisse.
• Superior Energy (SPN) and Rowan Cos. (RDC) to overweight from equal weight at Barclays.
• Tesoro (TSO) to outperform from neutral at Macquarie.
• Mechel (MTL) to buy from neutral at Goldman.
• SunPower (SPWRA), LDK Solar (LDK) and First Solar (FSLR) to buy from hold at ThinkEquity.

Continue reading Analyst Calls: AEO, AMP, DE, EBAY, FDX, FRO, FSLR, HBC, SPWR, TSO ...

Analyst Calls: AEO, AMP, DE, EBAY, FDX, FRO, FSLR, HBC, SPWR, TSO ... originally appeared on BloggingStocks on Mon, 29 Nov 2010 12:10:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Baird upgraded Oshkosh (OSK) to outperform from neutral, citing valuation as it believes post-Iraq U.S. military spending concerns are overdone. The firm keeps a $42 price target for shares.
• Goldman transferred coverage on CenturyTel (CTL) with a buy from a neutral and has a $42 price target on the stock. The firm believes CenturyTel could increase buybacks and or increase its dividend given free cash generation and low payout ratio.
• Lazard Capital upgraded Hatteras Financial (HTS) to buy from hold to reflect increased dividend projections. The firm has a $30 price target for shares.
• EOG Resources (EOG) was upgraded to neutral from underperform at Credit Suisse.
• Donaldson (DCI) was upgraded to neutral from underperform at BofA/Merrill.

Continue reading Analyst Calls: CTL, HTS, ISRG, MCD, MLM, OSK, RUTH, WMS, YUM ...

Analyst Calls: CTL, HTS, ISRG, MCD, MLM, OSK, RUTH, WMS, YUM ... originally appeared on BloggingStocks on Fri, 17 Sep 2010 11:30:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• UBS upgraded Salesforce.com (CRM) to Buy from Neutral based on positive feedback on the Chatter product and increasing confidence the company can beat FY11 guidance. The firm raised its price target to $111 from $90.
• Leerink upgraded Vivus (VVUS) to Outperform from Market Perform. The firm believes Qnexa issues raised by the FDA are labeling and marketing issues, and not approval issues. The firm expects a positive panel vote for Qnexa.
• Goldman upgraded AK Steel (AKS) to Buy from Netural citing lower iron ore prices. The firm has a $17 price target on the stock.
• Kinder Morgan Energy (KMP) was upgraded to Equal Weight at Morgan Stanley.
• Shire (SHPGY) was upgraded to Outperform from Neutral at Credit Suisse.
• Canadian National (CNI) was upgraded to Outperform from Market Perform at Raymond James.

Continue reading Analyst Calls: CRM, VVUS, AKS, KMP, SPWRA, TSL, JASO, ALL

Analyst Calls: CRM, VVUS, AKS, KMP, SPWRA, TSL, JASO, ALL originally appeared on BloggingStocks on Wed, 14 Jul 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Auriga upgraded Allscripts (MDRX) to buy from hold to reflect valuation and potential synergies from the company's pending merger with Eclipsys (ECLP). The firm upped its target price for shares to $20 from $19.
• SunTrust upgraded Newell Rubbermaid (NWL) to buy from neutral based on completion of its turnaround plan, stabilizing end markets and favorable comparisons. The firm has a $25 price target on the stock.
• Morgan Joseph upgraded C.R. Bard (BCR) to buy from hold based on valuation and upside to estimates from the share buyback program. The firm has a $97 price target on the stock.
• Shire (SHPGY) was upgraded to buy from hold at Lazard Capital.
• Onyx Pharma (ONXX) was upgraded to outperform from market perform at BMO Capital.
• AvalonBay (AVB) was upgraded to neutral from sell at UBS.

Continue reading Analyst Calls: AVB, BCR, CREE, DAI, HRB, HSP, MDRX, NANO, NWL ...

Analyst Calls: AVB, BCR, CREE, DAI, HRB, HSP, MDRX, NANO, NWL ... originally appeared on BloggingStocks on Thu, 08 Jul 2010 11:30:00 EST. Please see our terms for use of feeds.

Continue reading ADHD Patch Helps Investors Focus on Shire

ADHD Patch Helps Investors Focus on Shire originally appeared on BloggingStocks on Wed, 07 Jul 2010 18:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• FBR Capital upgraded Halliburton (HAL) to outperform from market perform as it sees less headline risk from the Gulf of Mexico spill following Wednesday's House Energy and Commerce Committee hearing. The firm upped its target for shares to $44 from $35.
• FBR Capital also upgraded Morgan Stanley (MS) to outperform from market perform as it views the valuation as attractive following the recent pullback in shares. The firm maintains a $35 price target for shares.
• Deutsche Bank upgraded Avnet (AVT) to buy from hold on valuation; it views the recent pullback as a buying opportunity. The firm raised its target for shares to $39 from $36.
• U.S. Steel (X) was upgraded to conviction buy from buy at Goldman.
• News Corp. (NWS) was upgraded to buy from hold at Argus.
• Sprint (S) was upgraded to outperform from market perform at Raymond James.

Continue reading Analyst Calls: AVT, COF, HAL, JACK, LEN, MS, NOK, NWS, S, TEVA, X ...

Analyst Calls: AVT, COF, HAL, JACK, LEN, MS, NOK, NWS, S, TEVA, X ... originally appeared on BloggingStocks on Thu, 13 May 2010 11:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Deutsche Bank upgraded Viacom (VIA) to buy from hold due to valuation and expectations that share buybacks will resume this year. The firm raised its price target on shares to $37 from $28.
• Canadian Natural (CNQ) was upgraded to outperform from neutral at Credit Suisse. The firm upgraded shares based on valuation and the outlook for heavy crude.
• UBS upgraded Key Energy (KEG) to buy from neutral, citing increased E&P well spending, a possible shorter term rally in gas activity and improved utilization. Target raised to $12.50 from $9.50.
• Shire (SHPGY) was raised to outperform from perform at Oppenheimer.
• PNC Financial (PNC) was upgraded at Bernstein to outperform from market perform.
• Pacer International (PACR) was upgraded to buy from hold at BB&T.

Continue reading Analyst Upgrades, Downgrades and Initiation: AXA, DNDN, HME, HRB, KEG, LTD, PNC, VIA ...

Analyst Upgrades, Downgrades and Initiation: AXA, DNDN, HME, HRB, KEG, LTD, PNC, VIA ... originally appeared on BloggingStocks on Mon, 22 Feb 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Deutsche Bank upgraded U.S. Steel (X) to buy from hold after raising its steel forecasts and upped its target price on shares to $77 from $44. Note, the firm also downgraded AK Steel.
• Credit Suisse upgraded Philip Morris (PM) to outperform from neutral based on a better international outlook.
• JPMorgan upgraded ev3 Inc. (EVVV) to overweight from neutral. The firm sees upside potential to ev3's consensus estimates for 2010 and raised its target price on shares to $19 from $15.
• Vale (VALE) was upgraded to overweight from equal weight at Barclays.
• Xilinx (XLNX) was raised to outperform from sector perform at RBC Capital.
• Shuffle Master (SHFL) was upgraded at KeyBanc to buy from hold.

Continue reading Analyst Upgrades, Downgrades and Initiations: AKS, EVVV, PEB, PM, PWR, S, X ...

Analyst Upgrades, Downgrades and Initiations: AKS, EVVV, PEB, PM, PWR, S, X ... originally appeared on BloggingStocks on Tue, 19 Jan 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Jefferies upgraded Starbucks (SBUX) to buy from hold, citing EPS and revenue momentum heading into 2010. The firm raised its target to $25 from $22.
• Soleil upgraded Zions Bancorp (ZION) to buy from hold on valuation as it believes the recent pullback provides an attractive entry point. The firm has a $17.50 price target on shares.
• RBC Capital expects Rigel Pharmaceuticals (RIGL) to sign a partnership for R788 in the next four months to run its global Phase III program. Shares were upgraded to outperform from sector perform and its target was raised to $11 from $9.
• Deere (DE) was upgraded to overweight from equal weight at Morgan Stanley.
• Shire (SHPGY) was raised to outperform from market perform at Bernstein.
• Ann Taylor (ANN) was upgraded to overweight from market weight at Thomas Weisel.
• J.M. Smucker (SJM) was upgraded to overweight from neutral at JPMorgan.

Continue reading Analyst upgrades, downgrades and initiations: ANN, AXP, CIEN, DE, RA, SBUX, ZION ...

Analyst upgrades, downgrades and initiations: ANN, AXP, CIEN, DE, RA, SBUX, ZION ... originally appeared on BloggingStocks on Mon, 23 Nov 2009 12:00:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Credit Suisse upgraded Sprint Nextel (S) to outperform from neutral and raised its target to $6 from $4. The firm believes Sprint Nextel's core business is turning and that valuation is attractive. Credit Suisse also added Sprint Nextel to its Focus List.
• Goldman expects Nordstrom (JWN) to benefit from a recovery in the high-end consumer. The firm upgraded shares to buy from neutral and raised its target to $41 from $39.
• Deutsche Bank remains cautious on the Dry Bulk sector long-term but expects increased Q4 day rates. The firm upgraded Genco (GNK) to buy from hold and raised its target to $31 from $24; the firm also upgraded Eagle Bulk (EGLE) to hold from sell.
• Steelcase (SCS) was upgraded to buy from hold at BB&T.
• United Rentals (URI) was upgraded to outperform from perform at Oppenheimer.
• GLG Partners (GLG) was upgraded to outperform from market perform at Keefe Bruyette.
• Ladish (LDSH) was upgraded to outperform from market perform at FBR Capital.

Continue reading Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ...

Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ... originally appeared on BloggingStocks on Mon, 16 Nov 2009 11:40:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Goldman upgraded CTC Media (NASDAQ: CTCM) to Buy from Neutral on a better outlook for European Media names and raised its target on shares to $17.60 from $12.
• Morgan Joseph upgraded Movado (NYSE: MOV) to Buy from Hold after the company reported better-than-expected Q2 results. The firm set a $16 target on the stock.
• Needham upgraded LTX Credence (NASDAQ: LTXC) to Strong Buy from Hold following the company's Q4 results with a $3 price target.
• Canon (NYSE: CAJ) was upgraded to Outperform from Underperform at Macquarie.
• Whitney Holding (NASDAQ: WTNY) was upgraded to Buy from Neutral at SunTrust.
• Gafisa SA (NYSE: GFA) was upgraded to Overweight from Equal Weight at Morgan Stanley.

Continue reading Analyst upgrades, downgrades and initiations: ANF, CAJ, CTCM, MOV, MV, VMED ...

Analyst upgrades, downgrades and initiations: ANF, CAJ, CTCM, MOV, MV, VMED ... originally appeared on BloggingStocks on Fri, 04 Sep 2009 10:50:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• B. Riley upgraded Finish Line (NASDAQ: FINL) to Buy from Neutral to reflect the potential for improving trends in second half of 2009. The firm raised its target on shares to $10.50 from $9.
• Merriman upgraded OptionXpress (NASDAQ: OXPS) to Neutral from Sell following the company's better than expected Q2 results. The firm notes higher commissions per trade more than offset weak DARTs and the decline in customer additions in the quarter.
• RBC Capital upgraded Gardner Denver (NYSE: GDI) to Outperform from Sector Perform and raised its target to $34 from $28 citing the additional scale of restructuring, better tone to end-markets, and few downside catalysts. Baird upgraded Gardner Denver to Outperform from Neutral and raised its target to $35 from $32 based on a bottom in fundamentals and compelling valuation.
• BE Aerospace (NASDAQ: BEAV) was upgraded to Outperform from Market Perform at FBR Capital.
• Shire (NASDAQ: SHPGY) was upgraded to Perform from Underperform at Oppenheimer.
• UnitedHealth (NYSE: UNH) was upgraded to Outperform from Neutral at Credit Suisse.

Continue reading Analyst upgrades, downgrades and initiations: BA, EXEL, FINL, NTAP, UNH, WU ...

Analyst upgrades, downgrades and initiations: BA, EXEL, FINL, NTAP, UNH, WU ... originally appeared on BloggingStocks on Mon, 27 Jul 2009 11:40:00 EST. Please see our terms for use of feeds.

• Canaccord upgraded Imperial Oil (NYSE: IMO) to Buy from Speculative Buy following an increase in crude oil forecast.
• BT Group (NYSE: BT) was upgraded to Outperform from Market Perform at Bernstein.
  
• Novartis (NYSE: NVS) was upgraded to Overweight from Neutral at JP Morgan.
  
• CommVault (NASDAQ: CVLT) was upgraded to Neutral from Sell at Goldman.
  
• AvalonBay (NYSE: AVB) was upgraded to Buy from Hold at Sandler O'Neill.

Continue reading Analyst upgrades, downgrades and initiations: BT, NVS, NOK, TXI, MTB ...

Analyst upgrades, downgrades and initiations: BT, NVS, NOK, TXI, MTB ... originally appeared on BloggingStocks on Fri, 17 Jul 2009 10:50:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Citigroup upgraded Abbott Lab (NYSE: ABT) to Hold from Sell on valuation following the stock's recent underperformance. The firm maintains a $48 price target.
  
• Deutsche Bank upgraded shares of Pepsi Bottling (NYSE: PBG) and Dr. Pepper Snapple (NYSE: DPS) to Buy from Hold as they believe carbonated soft drinks market is showing signs of stabilization. The firm raised its price target on Pepsi Bottling to $28 from $25 and on Dr. Pepper Snapple to $22 from $20.
  
• Baird upgraded CommScope (NYSE: CTV) to Outperform from Neutral and raised their target to $19 from $10 as they expect fundamentals to bottom in Q1 and ramp strongly in Q2 as wireless capex outlook improves.
• Sinopec Shanghai (NYSE: SHI) was raised to Buy from Sell at Goldman.
  
• TRW Automotive (NYSE: TRW) was upgraded at JP Morgan to Neutral from Underweight.

Continue reading Analyst upgrades, downgrades and initiations: ABT, DPS, BDK, AMZN, GS ...

Analyst upgrades, downgrades and initiations: ABT, DPS, BDK, AMZN, GS ... originally appeared on BloggingStocks on Thu, 02 Apr 2009 11:10:00 EST. Please see our terms for use of feeds.

One of the buzzwords that is currently in vogue in the investment community is biotechnology. This is a broad-based field that covers technological applications in any biological system, meaning humans, animals, agriculture, and medicines. This is a booming science and the investment field offers many opportunities for wealth accumulation.

If you don't want to spend countless hours trying to understand not just financials, but scientific and technical jargon that biotech companies harbor, exchange-traded funds (ETFs) may be the better choice for investing in the biotechnology industry.

An ETF is similar to buying a share of a company, but instead of getting one particular company you're investing in a bundle of companies within a particular field or specialty. It's a great way to invest in something you believe in while still hedging your bets and having a bit of diversity.

Continue reading A defensive investment: Biotechnology ETFs

A defensive investment: Biotechnology ETFs originally appeared on BloggingStocks on Sat, 07 Feb 2009 13:10:00 EST. Please see our terms for use of feeds.

• Baird upgraded Carlisle (NYSE:CSL) to Outperform from Neutral and lowered their target to $25 from $33 following the company's Q4 results citing attractive valuation and solid execution.
  
• Citigroup upgraded Talbots (NYSE:TLB) to Hold from Sell on valuation as they believe the company's cash flow is improving and does not expect the company to face bankruptcy in next three years.
  
• Jefferies upgraded shares of Spectra Energy (NYSE:SE) to Hold from Underperform on valuation following the company's Q4 results and raised their target price to $15 from $11.75.
• Costco (NASDAQ:COST) was upgraded to Buy from Neutral at UBS.
  
• AU Optronics (NYSE:AUO) and LG Display (NYSE:LPL) were upgraded to Buy from Neutral at Banc of America/Merrill.
  
• Alpha Natural (NYSE:ANR) was raised to Buy from Hold at Natixis.

Continue reading Analyst upgrades, downgrades and initiations: COST, LPL, SWCEY, AKAM, LEAP

Analyst upgrades, downgrades and initiations: COST, LPL, SWCEY, AKAM, LEAP originally appeared on BloggingStocks on Fri, 06 Feb 2009 11:50:00 EST. Please see our terms for use of feeds.

• Oppenheimer upgraded AmerisourceBergen (NYSE:ABC) to Outperform from Perform on the company's strong branded drug price inflation, potential for greater than expected buybacks, and their belief that prescription volume growth will stabilize after Q1. The firm raised their target to $45 from $36.
  
• Baird upgraded Ecolab (NYSE:ECL) to Outperform from Neutral based on valuation following reaffirmed guidance.
  
• Goldman removed shares of Dollar Tree (NASDAQ:DLTR) from its Conviction Sell List and upgraded it to Neutral from Sell based on valuation.
• Teppco Partners (NYSE:TPP) was upgraded to Outperform from Market Perform at Wachovia.
  
• Barrick Gold (NYSE:ABX) was raised to Buy from Hold at Canaccord.
  
• Coca Cola Femsa (NYSE: KOF)) was upgraded at Morgan Stanley to Overweight from Equal Weight.

• RBC Capital downgraded Apple (NASDAQ:AAPL) shares to Underperform from Sector Perform and lowered their target to $70 from $125 following the announcement that CEO Steve Jobs is taking a medical leave of absence. The analyst expects shares to be pressured by reduced earnings growth expectations and near-term leadership uncertainty.
  
• Barclays downgraded Motorola (NYSE:MOT) to Equal Weight from Overweight as they do not expect handset recovery for at least 6 to 9 months.
  
• Banc of America/Merrill downgraded Shire (NASDAQ:SHPGY) to Underperform from Buy based on earnings risk from the upcoming generic launch of Adderall XR.
• Royal Caribbean (NYSE:RCL) was added to Goldman's Conviction Sell List.
  
• Starent Networks (NASDAQ:STAR) and Ceragon Networks (NASDAQ:CRNT) were downgraded to Equal Weight from Overweight at Barclays.
  
• Casella Waste (NASDAQ:CWST) was lowered at JP Morgan to Neutral from Overweight.

• Citigroup initiated Cliffs Natural (NYSE:CLF) with a Buy rating and $43 target. The firm believes the company's multi-tier North American contract sales arrangements should allow it weather the volatility in the spot and seaborne markets and the firm expects volumes to improve in Q2.
  
• ING started Arcelor Mittal (NYSE:MT) with a Sell rating and believes the economic slowdown will have a greater than expected impact on the steel industry.
  
• Friedman Billings believes weakness in M&T Bank's (NYSE:MTB) regional economy could hinder the company's growth prospects and the firm is concerned about the bank's concentration in commercial and industrial loans. The firm has an Underperform rating and $30 target on the stock.
• S&T Bancorp (NASDAQ:STBA) was initiated with a Market Perform rating at Keefe Bruyette.
  
• RBC Capital initiated Norfolk Southern (NYSE:NSC) with a Sector Perform rating and $61 target.

Analyst upgrades, downgrades and initiations: AAPL, ABX, MOT, RL, CLF originally appeared on BloggingStocks on Thu, 15 Jan 2009 11:26:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Ericsson (NASDAQ: ERIC) was upgraded to Add from Hold at WestLB.
  
• JP Morgan upgraded Shire Plc (NASDAQ: SHPGY) to overweight from Neutral to reflect Vyvanse share gains and valuation.
  
• Wachovia upgraded Jefferies (NYSE: JEF) to Market Perform from Underperform because they believe that the recent collapse of the large cap bank sector, Jefferies' cash equity business, and the company's partial privatization as a result of its Leucadia investment will shield shares.
  
• Canaccord upgraded Amylin Pharma (NASDAQ: AMLN) to Hold from Sell.
• ADC Telecomm (NASDAQ: ADCT) was upgraded to Buy from Hold at Kaufman Bros. on valuation following the recent weakness.
• STEC Inc (NASDAQ: STEC) and Popular (NASDAQ: BPOP) were raised to Buy from Neutral at B. Riley.
  

• Merrill downgraded Disney (NYSE: DIS) to Underperform from Neutral and cut its target to $27 from $34 citing the impact from the current economic climate on earnings.
  
• Barclays downgraded IBM (NYSE: IBM) to Equal Weight from Overweight citing the impact from the weakening economy and the company's large exposure to the financial services industry. IBM's target was cut to $108 from $130.
  
• Jefferies downgraded Salesforce.com (NYSE: CRM) to Underperform from Buy on increased risks of deteriorating payment terms and price pressure on renewals. The company's target was lowered to $36 from $75.
• Goldman downgraded First Solar (NASDAQ: FSLR) and added shares to the Conviction Sell List.

Continue reading Analyst calls: ERIC, AMLN, DIS, IBM, CRM, FSLR, NOK, ALU ...

Analyst calls: ERIC, AMLN, DIS, IBM, CRM, FSLR, NOK, ALU ... originally appeared on BloggingStocks on Tue, 07 Oct 2008 11:25:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Goldman upgraded shares of Shire Plc (NASDAQ: SHPGY) to Buy from Neutral on expectations for share gains in the second half of 2008 following the launch of Vyvanse in adults. Goldman also added the stock to the Conviction Buy List.
  
• Deutsche Bank raised J.C. Penney (NYSE: JCP) to Buy from Hold after channel checks indicated recent sales trends have improved. The firm finds the risk/reward compelling at current levels with a $46 target.
  
• Oppenheimer upgraded shares of VisionChina Media (NASDAQ: VISN) to Outperform from Perform following the recent pullback, after channel checks indicated the company is seeing greater traction with larger advertising clients.

• National Oilwell Varco (NYSE: NOV) was upgraded to Sector Perform from Underperform.
  
• Goldman added US Steel (NYSE: X) to the Conviction Buy List.
  
• Apollo Group (NASDAQ: APOL) was upgraded at ThinkPanmure to Buy from Accumulate.

Analyst upgrades: SHPGY, JCP, VISN, NOV, X, APOL originally appeared on BloggingStocks on Mon, 23 Jun 2008 11:30:00 EST. Please see our terms for use of feeds.

• PDUFA date for Genentech, Inc. (NYSE: DNA) and Roche Holding Ltd. (OTC: RHHBY)'s supplemental Biologics License Application for Herceptin for label expansion to include AC followed by docetaxel in treatment of adjuvant HER2+ breast cancer.
• PDUFA date for Shire plc (NASDAQ: SHPGY) and New River Pharma's supplemental New Drug Application for Vyvanse (NRP-104) treatment of Attention Deficit Hyperactivity Disordre, or ADHD, in adult patients 18-55 years old; the drug is already approved for pediatric ADHD ages 6-12.
• Verizon Communications Inc. (NYSE: VZ) to report Q earnings; conference call at 8:30am.
• Tyson Foods, Inc. (NYSE: TSN) to report Q2 earnings; conference call at 9:00am.

• Two-day FOMC meeting beginning at 8:30am.
• PDUFA date for Merck & Co., Inc. (NYSE: MRK)'s New Drug Application for Cordaptive (MK-0524A) adjunctive therapy to diet for treating elevated LDL Cholesterol, low HDL Cholesterol and elevated triglycerides levels.
  
• PDUFA date for Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)'s supplemental New Drug Application for dose of 8mg treatment of Irritable Bowel Syndrome with Constipation; already approved for Chronic Idiopathic Constipation at 24ug dosage.
• BP plc (NYSE: BP) to report Q1 earnings; conference call at 10:15am.
• United States Steel Company (NYSE: X) to report Q1 earnings; conference call at 2:00pm.

Continue reading Market highlights for next week: Two-day FOMC meeting

Market highlights for next week: Two-day FOMC meeting originally appeared on BloggingStocks on Fri, 25 Apr 2008 16:37:00 EST. Please see our terms for use of feeds.